These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20821979)

  • 1. [Cardiotoxic effects of breast cancer chemotherapy and their possible correction].
    Reznikova EA; Kosenok VK; Nechaeva GI; Merkulov VN; Reznikov AS
    Eksp Klin Farmakol; 2010 Jul; 73(7):36-9. PubMed ID: 20821979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment].
    Cherenkov VG; Petrov AB; Shpenkova AA; Vasil'eva TM
    Vopr Onkol; 2012; 58(1):110-4. PubMed ID: 22629839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reamberin in combined therapy of general peritonitis].
    Kosinets VA; Sachek MG; Kondratenko GG
    Khirurgiia (Mosk); 2010; (1):59-63. PubMed ID: 20336047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
    Jensen BV
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S15-21. PubMed ID: 16781285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Therapy Insight: anthracyclines and trastuzumab--the optimal management of cardiotoxic side effects.
    Magné N; Chargari C
    Nat Clin Pract Oncol; 2008 Nov; 5(11):E1. PubMed ID: 18957967
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI.
    Nagy AC; Tolnay E; Nagykálnai T; Forster T
    Neoplasma; 2006; 53(6):511-7. PubMed ID: 17167721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reamberin for pathogenetic therapy of acute and chronic viral diseases of the liver].
    Sologub TV; Romantsov MG; Shul'diakov AA; Radchenko VG; Stel'makh VV; Kovalenko AL; Esaulenko EV; Isakov VA
    Klin Med (Mosk); 2010; 88(4):68-71. PubMed ID: 20919574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastrointestinal injuries in patients with breast cancer treated with chemotherapy].
    Koroleva IA; Vel'sher LZ; Kaziulin AN; Kucheriavyĭ IuA; Oganesian TS
    Vopr Onkol; 2010; 56(2):206-9. PubMed ID: 20552899
    [No Abstract]   [Full Text] [Related]  

  • 9. [Free radical processes at patients with pathologies of biliary ducts and methods of their correction].
    Bolevich SB; Stupin VA; Gakhramanov TV; Khokonov MA; Silina EV; Men'shova NI; Bogdanova LS
    Khirurgiia (Mosk); 2010; (7):65-70. PubMed ID: 20724982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Subclinical heart damage caused by adjuvant anthracycline chemotherapy].
    Dunst J
    Strahlenther Onkol; 2002 Feb; 178(2):110-1. PubMed ID: 11942035
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adjuvant chemotherapy with anthracyclines in comparison with the standard combination of CMF in breast cancer with high risk of relapse].
    Semiglazov VF; Bozhok AA; Ivanova OA; Ivanov VG; Arzumanov AS; Barash NIu; Orlov AA; Golubëva OM; Topuzov EE; Seleznev IK; Migmanova NSh; Popova PT; Brezhneva TV; Paltuev RM
    Vopr Onkol; 2000; 46(2):160-6. PubMed ID: 10853413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
    Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
    Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer.
    Du XL; Xia R; Liu CC; Cormier JN; Xing Y; Hardy D; Chan W; Burau K
    Cancer; 2009 Nov; 115(22):5296-308. PubMed ID: 19672997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines.
    Dranitsaris G; Rayson D; Vincent M; Chang J; Gelmon K; Sandor D; Reardon G
    Breast Cancer Res Treat; 2008 Feb; 107(3):443-50. PubMed ID: 17978870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heart of the matter.
    Portera CC; Swain SM
    J Clin Oncol; 2007 Sep; 25(25):3794-6. PubMed ID: 17664459
    [No Abstract]   [Full Text] [Related]  

  • 17. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between hormonal receptors, HER-2, p53 protein, Bcl-2, and MIB-1 status and the antitumor effects of neoadjuvant anthracycline-based chemotherapy in invasive breast cancer patients.
    Kariya S; Ogawa Y; Nishioka A; Moriki T; Ohnishi T; Ito S; Murata Y; Yoshida S
    Radiat Med; 2005 May; 23(3):189-94. PubMed ID: 15940066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oxidative stress in patients with mechanical jaundice of different origin and severity].
    Silina EV; Stupin VA; Gakhramanov TV; Khokonov MA; Bolevich SB; Men'shova NI; Sinel'nikova TG
    Klin Med (Mosk); 2011; 89(3):57-63. PubMed ID: 21861407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.
    Luck HJ; Thomssen C; duBois A; Lisboa BW; Untch M; Kuhnle H; Konecny G; Janicke F; Meerpohl HG; Lindner C; Hecker D; Diergarten K
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):33-6. PubMed ID: 8629034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.